Replies to post #223731 on Biotech Values

[rfj1862]

I agree, but I don't see that happening this year.

Actually I would not be surprised if they already have had expressions of interest, given where they are doing most of their initial studies and the close relationship of the CAR-T companies (Novartis, Juno/Celgene/BMS) as well as Amgen with the same site.

Also: "The Company also announced that it is now a resident company at Johnson & Johnson Innovation – JLABS (JLABS at TMC), an incubator located in the heart of the Texas Medical Center, to access a fully equipped laboratory to conduct research and development."

Seems like a cheap way for these companies to acquire the next stage in technology.